Vivimed Labs Ltd Locks at Lower Circuit With 1.83% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the BE series, hit its lower circuit at Rs 5.37, marking the maximum allowed daily loss of 1.83% within a 2% price band. This price band is relatively narrow compared to the more common 5% or 10% bands seen in other segments, reflecting the stock’s micro-cap status and the exchange’s attempt to limit volatility. The circuit lock indicates that supply overwhelmed demand to the point where the exchange floor intervened, effectively freezing trading at the floor price. Sellers were lined up, but buyers were absent, creating a classic case of unfilled supply. This scenario is particularly concerning for micro-cap stocks like Vivimed Labs Ltd, where liquidity is thin and exit options are limited — how deep is the exit problem for Vivimed Labs and what would need to change for normal trading to resume?

Delivery and Volume Analysis

Delivery volumes surged dramatically on 21 Sep 2026, with 36,560 shares delivered — a rise of 957.78% compared to the 5-day average delivery volume. On a lower circuit day, this spike in delivery volume is a significant signal: it reflects genuine selling by holders liquidating actual positions rather than speculative short-selling. The total traded volume was 26,460 shares, with a turnover of just Rs 0.00142 crore, underscoring the limited liquidity. The delivery data on a lower circuit day has a specific meaning — and it's not the same as on an upper circuit. Rising delivery volumes during a sell-off of this magnitude point to genuine liquidation, not speculative shorting — is this capitulation or just the beginning for Vivimed Labs?

Intraday Price Action

The intraday range was narrow, with the stock opening and closing at Rs 5.37, the circuit floor price. There was no meaningful trade above this level during the session, indicating that the selling pressure was present from the outset and buyers were absent throughout. This contrasts with scenarios where a stock opens higher and then cascades down to the circuit, which would suggest a more volatile intraday sell-off. Here, the immediate lock at the lower circuit reflects persistent selling interest and a lack of demand — does the technical profile of Vivimed Labs show any nearby support, or is more downside likely?

Moving Averages and Trend Context

Vivimed Labs Ltd is trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a sustained downtrend that preceded the lower circuit event. The stock has been losing ground for 11 consecutive sessions, accumulating an 18.39% decline over this period. The technical picture suggests that the lower circuit is not an isolated event but rather an acceleration of existing weakness. The absence of any short-term moving average support raises the question of whether the stock is approaching oversold territory or if the selling pressure has further to run — after a 1.83% single-day loss at lower circuit, is Vivimed Labs approaching oversold territory or does the selling pressure have further to run?

Liquidity and Exit Risk

With a market capitalisation of approximately Rs 47 crore, Vivimed Labs Ltd is classified as a micro-cap stock. The liquidity profile is thin, with a trade size of effectively Rs 0 crore based on 2% of the 5-day average traded value. This limited liquidity compounds the exit risk for sellers, especially when the stock is locked at the lower circuit. Sellers who wish to exit positions face severe friction, as the unfilled supply accumulates and buyers remain absent. This scenario can lead to multi-day circuit locks, trapping holders on the wrong side of the trade. The micro-cap trap is a critical consideration here — how deep is the exit problem for Vivimed Labs and what would need to change for normal trading to resume?

Brief Fundamental Context

Vivimed Labs Ltd operates in the Pharmaceuticals & Drugs industry, a sector that often experiences volatility linked to regulatory developments and market sentiment. While the company’s micro-cap status exposes it to amplified price swings, the current technical and volume data suggest that the recent selling pressure is driven by genuine liquidation rather than speculative trading. The stock’s performance today underperformed its sector by 1.75%, while the Sensex declined marginally by 0.04%, indicating that the move is largely stock-specific rather than market-driven.

Conclusion: Severity Assessment with Liquidity Caveats

The lower circuit lock at Rs 5.37 for Vivimed Labs Ltd reflects a session dominated by genuine selling pressure, as evidenced by the surge in delivery volumes and the absence of buyers. The stock’s position below all major moving averages confirms the technical weakness that has been building over the past weeks. The micro-cap status and limited liquidity exacerbate the exit risk, potentially prolonging the period of price stagnation at the circuit floor. The total traded volume was low, but this is a mechanical effect of the circuit lock rather than a sign of easing selling pressure. The question remains whether this represents capitulation or if further selling lies ahead — is this capitulation or just the beginning for Vivimed Labs?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today